Similar Papers

Paper Title
Journal
Date
Author
Chemotherapy for recurrent and metastatic cervical cancer
Xia Tao ... John J Kavanagh
Gynecologic Oncology | VOL. 110
Xia Tao, et. al.Xia Tao ... John J Kavanagh
03 Jun 2008
Efficacy and safety of camrelizumab in combination with radiation and chemotherapy for recurrent or metastatic cervical cancer.
Zhongjie Chen ... Jun Wang
Journal of Clinical Oncology | VOL. 41
Zhongjie Chen, et. al.Zhongjie Chen ... Jun Wang
01 Jun 2023
Maintenance Therapy for Recurrent or Metastatic Cervical Cancer: A Multicenter, Cohort Study
C Peng ... P Xie
International Journal of Radiation Oncology*Biology*Physics | VOL. 117
C Peng, et. al.C Peng ... P Xie
29 Sep 2023
Maintenance therapy for patients with recurrent or metastatic cervical cancer: A multicentre, cohort study.
Chen Peng ... Peng Xie
Journal of Clinical Oncology | VOL. 41
Chen Peng, et. al.Chen Peng ... Peng Xie
01 Jun 2023
View more papers

More From: Gynecologic Oncology

Paper Title
Journal
Date
Author
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management.
Andrea Neilson ... Jessica N Mcalpine
Gynecologic oncology | VOL. 193
Andrea Neilson, et. al.Andrea Neilson ... Jessica N Mcalpine
01 Feb 2025
What happens after menopause? (WHAM): A prospective controlled study of cognition 24 months after premenopausal risk-reducing salpingo-oophorectomy
Pauline M Maki ... Martha Hickey
Gynecologic Oncology | VOL. -
Pauline M Maki, et. al.Pauline M Maki ... Martha Hickey
01 Feb 2025
Added prognostic value of sentinel lymph node mapping in endometrial cancer to molecular subgroups
Franziska Siegenthaler ... Michael D Mueller
Gynecologic Oncology | VOL. 193
Franziska Siegenthaler, et. al.Franziska Siegenthaler ... Michael D Mueller
01 Feb 2025
Barriers to early detection: Insurance denials for breast MRI screening in women with germline BRCA1/2 mutations
S Gordhandas ... E Aviki
Gynecologic Oncology | VOL. 193
S Gordhandas, et. al.S Gordhandas ... E Aviki
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.